Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mUlticenter, Single-arM, Open-laBel, Long-teRm Safety Study With macitEntan in Patients With puLmonary Arterial Hypertension previousLy Treated With mAcitentan in Clinical Studies

NCT03422328 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT03422328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mUlticenter, Single-arM, Open-laBel, Long-teRm Safety Study With macitEntan in Patients With puLmonary Arterial Hypertension previousLy Treated With mAcitentan in Clinical Studies
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
April 5, 2018
Completion date
December 27, 2023
Enrollment
151 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension